ATE217797T1 - Antiinflammatorischen faktor enthaltende zusammensetzungen , verfahren zur herstellung und verwendung - Google Patents

Antiinflammatorischen faktor enthaltende zusammensetzungen , verfahren zur herstellung und verwendung

Info

Publication number
ATE217797T1
ATE217797T1 AT93922286T AT93922286T ATE217797T1 AT E217797 T1 ATE217797 T1 AT E217797T1 AT 93922286 T AT93922286 T AT 93922286T AT 93922286 T AT93922286 T AT 93922286T AT E217797 T1 ATE217797 T1 AT E217797T1
Authority
AT
Austria
Prior art keywords
preparation
inflammatory factor
compositions containing
containing anti
factor
Prior art date
Application number
AT93922286T
Other languages
English (en)
Inventor
Lee R Beck
Original Assignee
Stolle Milk Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Milk Biologics Inc filed Critical Stolle Milk Biologics Inc
Application granted granted Critical
Publication of ATE217797T1 publication Critical patent/ATE217797T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93922286T 1992-10-27 1993-09-22 Antiinflammatorischen faktor enthaltende zusammensetzungen , verfahren zur herstellung und verwendung ATE217797T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/966,741 US5352462A (en) 1982-06-03 1992-10-27 Anti-inflammatory factor, method of isolation, and use
PCT/US1993/008935 WO1994009799A1 (en) 1992-10-27 1993-09-22 Anti-inflammatory factor, method of isolation, and use

Publications (1)

Publication Number Publication Date
ATE217797T1 true ATE217797T1 (de) 2002-06-15

Family

ID=25511810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93922286T ATE217797T1 (de) 1992-10-27 1993-09-22 Antiinflammatorischen faktor enthaltende zusammensetzungen , verfahren zur herstellung und verwendung

Country Status (15)

Country Link
US (1) US5352462A (de)
EP (1) EP0746329B1 (de)
JP (3) JPH08502515A (de)
KR (1) KR100310899B1 (de)
AT (1) ATE217797T1 (de)
AU (1) AU679006B2 (de)
CA (1) CA2146442C (de)
DE (1) DE69331957T2 (de)
FI (1) FI115383B (de)
IL (2) IL107392A (de)
MX (1) MX9306686A (de)
NO (1) NO951570L (de)
NZ (1) NZ256576A (de)
TW (1) TW389695B (de)
WO (1) WO1994009799A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
DE19548221C1 (de) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände
NZ504132A (en) * 1996-03-26 2002-03-28 Dcv Inc Anti-inflammatory composition from avian eggs, method of isolation and use in treating and preventing inflammation
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
JP4451933B2 (ja) * 1996-12-27 2010-04-14 住友化学株式会社 遺伝子操作による植物へのｐｐｏ阻害性除草剤耐性付与法
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AU6726500A (en) * 1999-08-24 2001-03-19 Nomoto, Kikuo Methods of pasteurizing immune substance containing antiinflammatory factor and utilization thereof
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
CH590064A5 (de) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk
JPS58136137A (ja) * 1982-02-08 1983-08-13 Hitachi Ltd 電界効果トランジスタを用いたインバータ回路
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
JPS6049377A (ja) * 1983-08-30 1985-03-18 Canon Inc 画像処理装置
JPS6135616A (ja) * 1984-07-27 1986-02-20 Tdk Corp 電界効果トランジスタ駆動回路
JPS63139421A (ja) * 1986-12-01 1988-06-11 Fuji Electric Co Ltd Ｍｏｓｆｅｔのゲ−ト駆動回路
EP0300102B1 (de) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung
JPH022704A (ja) * 1988-06-15 1990-01-08 Matsushita Electric Works Ltd 半導体スイッチング素子の駆動回路
JPH0250616A (ja) * 1988-08-12 1990-02-20 Matsushita Electric Works Ltd トランジスタ駆動回路
US4897580A (en) * 1989-06-20 1990-01-30 Motorola Inc. Amplifier drive circuit for inductive loads

Also Published As

Publication number Publication date
CA2146442C (en) 2005-01-25
CA2146442A1 (en) 1994-05-11
FI115383B (fi) 2005-04-29
EP0746329A4 (de) 1996-06-18
DE69331957D1 (de) 2002-06-27
IL121464A0 (en) 1998-02-08
MX9306686A (es) 1994-06-30
AU679006B2 (en) 1997-06-19
JP2006036785A (ja) 2006-02-09
IL107392A (en) 1998-09-24
JPH08502515A (ja) 1996-03-19
FI951980L (fi) 1995-05-31
TW389695B (en) 2000-05-11
NO951570L (no) 1995-06-26
NZ256576A (en) 1997-05-26
EP0746329A1 (de) 1996-12-11
KR100310899B1 (ko) 2001-12-17
IL107392A0 (en) 1994-01-25
FI951980A0 (fi) 1995-04-26
KR950703983A (ko) 1995-11-17
NO951570D0 (no) 1995-04-25
AU5134093A (en) 1994-05-24
DE69331957T2 (de) 2003-01-16
WO1994009799A1 (en) 1994-05-11
EP0746329B1 (de) 2002-05-22
US5352462A (en) 1994-10-04
JP2008074861A (ja) 2008-04-03

Similar Documents

Publication Publication Date Title
ATE217797T1 (de) Antiinflammatorischen faktor enthaltende zusammensetzungen , verfahren zur herstellung und verwendung
DE59704070D1 (de) Verfahren zur Herstellung von höheren Oxo-Alkoholen
EP2123665A3 (de) Inhibitoren des Interleukin-1$g(b) Konversionsenzyms
ATE15973T1 (de) Verfahren zur fraktionierung von blutplasma.
FR2729570B1 (de)
AU667530B2 (en) Removal of antibodies from blood-derived compositions while retaining coagulation factors
DE69611957D1 (de) Verfahren zur Herstellung von Goldpulver durch Aerosolzersetzungen
DE69302771D1 (de) Verfahren zur Herstellung von gesintertem Siliciumnitrid
ATE211916T1 (de) Entzündungshemmende faktor, methode seiner isolation und verwendung
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
DE3485909D1 (de) Verfahren zur herstellung von whiskers aus siliciumnitrid vom beta-typ.
DE69130227D1 (de) Verfahren zur herstellung von verbesserte hypereutektische legierungen und auf diesen basierte verbundwerkstoffe
HUT49122A (en) Process for producing pharmaceutical compositions containing pyridyl-ethanol-amine as active component and the active component
DE69511818D1 (de) Verfahren zur Herstellung von Sinterkörpern aus Siliciumnitrid
MY117908A (en) Anti-inflammatory factor, method of isolation, and use
IE880390L (en) Fused azepinone and azocinone derivatives, processes for¹their preparation, agents containing them and their use, and¹intermediates in their preparation
EP0586953A3 (de) Techniken zur Erzeugung von Sprachpostnachrichten aus unterschiedlichen Texteingängen.
ATE182365T1 (de) Verfahren zur herstellung von pilocarpin
DE59109098D1 (de) Pteridin-Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung zur Herstellung von Immunogenen
ATE18071T1 (de) Verfahren zur vorbereitung von alloplastischen implantationen und organtransplantationen.
DE59304579D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-5-hydroxyoxindolen und deren Etherderivaten
ATE91709T1 (de) Verfahren zur entfernung unerwuenschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikoerper und dafuer geeigneter kit.
DE68909216D1 (de) Hochwirksames photolumineszentes Material für optische Umwandlung und Verfahren zur Herstellung desselben.
ATE93267T1 (de) Verfahren zur herstellung entalkoholisierter getraenke sowie anlage und einrichtung zur durchfuehrung des verfahrens.
WO2001045681A3 (en) Naphthoquinone derivatives as cd45 inhibitors